Engineers Gate Manager’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-37
Closed -$34K 2344
2021
Q4
$34K Buy
+37
New +$39.7K ﹤0.01% 1906
2021
Q3
Sell
-17
Closed -$55K 2008
2021
Q2
$55K Sell
17
-10
-37% -$39.6K ﹤0.01% 1544
2021
Q1
$168K Buy
27
+22
+440% +$160K 0.01% 1636
2020
Q4
$26K Buy
5
+2
+67% +$12.6K ﹤0.01% 1648
2020
Q3
$18K Sell
3
-5
-63% -$29.2K ﹤0.01% 1626
2020
Q2
$47K Buy
+8
New +$54.2K ﹤0.01% 1643
2019
Q2
Sell
-5
Closed -$147K 1396
2019
Q1
$147K Buy
+5
New +$120K 0.01% 854

Other funds holding YARW

Engineers Gate Manager's YARW Position: Q1 2022 in Review

Engineers Gate Manager sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q1 2022, closing a stake of 37 shares — an estimated $34K sold.

Engineers Gate Manager first reported a position in YARW in Q1 2019 and held it in 7 quarters. The position peaked at $168K in Q1 2021. 41 funds tracked by Wall St. Rank hold YARW as of Q1 2022.

  • Engineers Gate Manager reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Engineers Gate Manager sold 37 Yarrow Bioscience, Inc. Common Stock shares in Q1 2022, an estimated $34K.
  • Engineers Gate Manager first reported a position in Yarrow Bioscience, Inc. Common Stock in Q1 2019 and held it in 7 quarters.
  • Engineers Gate Manager's Yarrow Bioscience, Inc. Common Stock position peaked at $168K in Q1 2021.
  • 41 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2022.

Based on Engineers Gate Manager's 13F filing for Q1 2022, filed 16 May 2022.